Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tedgui

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Circulation|December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalphaA Mamontova, S Séguret-Macé, B Esposito, et al.
The Journal of Biological Chemistry|November 5, 1999
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1P Delerive, K De Bosscher, S Besnard, et al.
Circulation|May 24, 2000
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptorsG Chinetti, F G Gbaguidi, S Griglio, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonistsO Morel, B Hugel, L Jesel, et al.
Nature|July 9, 1998
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activatorsB Staels, W Koenig, A Habib, et al.
Circulation Research|October 16, 1999
Protective role of interleukin-10 in atherosclerosisZ Mallat, S Besnard, M Duriez, et al.
Cancer Metastasis Reviews|January 21, 2011
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapyEric Tartour, H Pere, B Maillere, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Circulation|December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalphaA Mamontova, S Séguret-Macé, B Esposito, et al.
The Journal of Biological Chemistry|November 5, 1999
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1P Delerive, K De Bosscher, S Besnard, et al.
Circulation|May 24, 2000
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptorsG Chinetti, F G Gbaguidi, S Griglio, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonistsO Morel, B Hugel, L Jesel, et al.
Nature|July 9, 1998
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activatorsB Staels, W Koenig, A Habib, et al.
Circulation Research|October 16, 1999
Protective role of interleukin-10 in atherosclerosisZ Mallat, S Besnard, M Duriez, et al.
Cancer Metastasis Reviews|January 21, 2011
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapyEric Tartour, H Pere, B Maillere, et al.
Pageof 14